Course directors
- Antonio C. Pagano Zottola (Bordeaux Institute of Oncology – INSERM, France)
- Anna Golebiewska (Luxembourg Institute of Health, Luxembourg)
- Varun Venkataramani (German Cancer Research Center, Germany)
September 22 – 11:00am
Anna Golebiewska (Luxembourg Institute of Health, Luxembourg)
Heterogeneity and plasticity of the brain tumor ecosystem: What can we learn from advanced patient-derived models?
September 23 – 9:00am
Simona Parrinello (University College London, UK)
Injury programmes shape gliomagenesis.
September 23 – 11:00am
Henrik Heiland (Dep. of Neurosurgery, University Clinic Erlangen, Germany)
September 25 – 9:00am
Hélène Castel (Cancer and Brain Genomics, Inserm, University of Rouen, France)
Neurosciences in Oncology: When Cancer Thinks Out of the Box.
September 25 – 11:00am
Thomas Daubon (CNRS, University of Bordeaux, France)
Lactate Shuttle between Glioblastoma Cells and Neurons: a Cancer Neuroscience Case.
September 29 – 9:00am
Franck Winkler (University of Heidelberg, Germany)
Cancer Neuroscience of Brain Tumors.
September 29 – 11:00am
Vidhya M. Ravi (Medical Centre University Clinic of Freiburg, Germany)
Tumor–Host Interdependence: Decoding the Microenvironmental Dialogue.
October 2 – 9:00am
Hrvoye Miletic (University of Bergen, Norway)
Cell communication and mitochondria transfer in brain tumors.
October 2 – 11:00am
Manuel Valiente (Spanish National Cancer Research Centre, Spain)
The Evolving Landscape of Brain Metastases.
October 3 – 9:00am
Leila Akkari (Netherlands Cancer Institute, The Netherlands)
Macrophages: Jack of all Trades in the Brain Ecosystem?
October 6 – 9:00am
Varun Venkataramani (German Cancer Research Center, Germany)
October 6 – 11:00am
Aurélie Tchoghandjian (Institute of Neurophysiopathology, Marseille, France)
Glioblastoma stemness and immunosuppression: breaking the lethal cycle.
October 9 – 9:00am
Antonio Pagano Zottola (Bordeaux Institute of Oncology, University of Bordeaux, France)
MitoDREADD: a new mitochondria-specific chemogenetic tool.
Maialen Arrieta, Institut de Biochimie et Génétique Cellulaires, France
Chiara Bastiancich, Institut de Neurophysiopathologie, France
Doriane Bomont, Institut de Biochimie et Génétique Cellulaires, France
Clementine Bosch Bouju, NutriNeuro, Bordeaux University, France
Kevin Boyé, Paris Cardiovascular Research Center, France
Lucie Brisson, Bordeaux Institute of Oncology, France
Audrey Burban, Institut de Biochimie et Génétique Cellulaires, France
Thomas Daubon, Institut de Biochimie et Génétique Cellulaires, France
Ahmad Sharanek, Bordeaux Institute of Oncology, France
Emanuelle Georget, Bordeaux Institute of Oncology
Nassim Haffiane, IINS, Bordeaux University, France
Maria Haykal, Institut de Biochimie et Génétique Cellulaires, France
Camille Humeau, Bordeaux Institute of Oncology, France
Valentina Lopardo, Università di Salerno, Italy
Oceane Martin, Institut de Biochimie et Génétique Cellulaires, France
Pilar Moreno-Sanchez, Luxembourg Institute of Health, Luxembourg
Clement Morgat, INCIA, Bordeaux University, France
Ekin Reyhan, Universität Heidelberg, Germany
Mahsa Rezaeipour, Luxembourg Institute of Health, Luxembourg
Beatrice Senigagliesi, IINS, Bordeaux University, France
Kirill Smirnov, Institut de Psychiatrie et Neurosciences de Paris, France
Stella Soyka, Universität Heidelberg, Germany
Cloe Tessier, Bordeaux Institute of Oncology, France
Claire Larrieu, IBGC Bordeaux, France
Bastien Redon, Neurocentre Magendie, Bordeaux University, France